Potent inhibitor of cell adhesion. Inhibits tumor cell adhesion to laminin and vitronectin substrates. In vivo investigations in rats showed it to be useful in the amelioration of ischemic acute renal failure in rats. Also inhibits tubular obstruction by preventing cell-cell adhesion. Inhibits the redistribution of c-Src into focal adhesions, thereby leading to impaired MAP Kinase activation.
生化/生理作用
Cell permeable: no
Primary Target inhibits tumor cell adhesion to laminin and vitronectin substrates
Product does not compete with ATP.
Reversible: no
警告
Toxicity: Standard Handling (A)
其他說明
Shono, T., et al. 2001. Exp. Cell Res.268, 169. Matsuno, H., et al. 1994. Circulation 90, 2203. Noiri, E., et al. 1994. Kidney Int. 46, 1050. Gurrath, M., et al. 1992. Eur. J. Biochem. 210, 911.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany